郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.

期刊：Human psychopharmacology发表年份：2017作者：Isabella Canazza; Andrea Ossato; Fabrizio Vincenzi; Adolfo Gregori; Fabiana Di Rosa; Federica Nigro; Alessandro Rimessi; Paolo Pinton; Katia Varani; Pier Andrea Borea; Matteo Marti
阅读更多 →

药效评价A Novel Selective Inverse Agonist of the CB2 Receptor as a Radiolabeled Tool Compound for Kinetic Binding Studies.

期刊：Molecular pharmacology发表年份：2017作者：Andrea Martella; Huub Sijben; Arne C Rufer; Uwe Grether; Juergen Fingerle; Christoph Ullmer; Thomas Hartung; Adriaan P IJzerman; Mario van der Stelt; Laura H Heitman
阅读更多 →

药效评价A common mechanism for CFTR potentiators.

期刊：The Journal of general physiology发表年份：2017作者：Han-I Yeh; Yoshiro Sohma; Katja Conrath; Tzyh-Chang Hwang
阅读更多 →

药效评价Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile.

期刊：Bioorganic & medicinal chemistry发表年份：2017作者：Vittorio Canale; Anna Partyka; Rafał Kurczab; Martyna Krawczyk; Tomasz Kos; Grzegorz Satała; Bartłomiej Kubica; Magdalena Jastrzębska-Więsek; Anna Wesołowska; Andrzej J Bojarski; Piotr Popik; Paweł Zajdel
阅读更多 →